TRCT
PBAXU

Tower Research Capital (TRC)’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Tower Research Capital (TRC)’s Portfolio PBAXU Stock Details PBAXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-175
Closed -$1.87K – 6309
2023
Q4 		$1.87K Hold
175
– – ﹤0.01% 5306
2023
Q3 		$1.99K Hold
175
– – ﹤0.01% 5230
2023
Q2 		$1.83K Hold
175
– – ﹤0.01% 5305
2023
Q1 		$2K Hold
175
– – ﹤0.01% 5436
2022
Q4 		$2K Hold
175
– – ﹤0.01% 5472
2022
Q3 		$2K Hold
175
– – ﹤0.01% 5657
2022
Q2 		$2K Hold
175
– – ﹤0.01% 5645
2022
Q1 		$2K Hold
175
– – ﹤0.01% 5647
2021
Q4 		$2K Buy
+175
New +$1.77K ﹤0.01% 5709

Tower Research Capital (TRC)'s PBAXU Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q1 2024, closing a stake of 175 shares — an estimated $1.87K sold.

Tower Research Capital (TRC) first reported a position in PBAXU in Q4 2021 and held it in 9 quarters. The position peaked at $2K in Q1 2023. 0 funds tracked by Wall St. Rank hold PBAXU as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 175 Phoenix Biotech Acquisition Corp. Unit shares in Q1 2024, an estimated $1.87K.
  • Tower Research Capital (TRC) first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s Phoenix Biotech Acquisition Corp. Unit position peaked at $2K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.